Beam Therapeutics is one of the leading companies in base editing, a next-generation gene editing approach designed to make precise single-base changes without creating double-strand DNA breaks. This technology gives Beam a differentiated position within genetic medicine.

Bayer Pharmaceuticals remains a major global pharmaceutical business within Bayer AG, with strengths in cardiovascular medicine, ophthalmology, women’s health, oncology, hematology, and specialty care. Although Bayer as a group has faced significant pressures from its agricultural business and debt profile, its pharmaceutical division remains a relevant global platform.

Bavarian Nordic is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

Axsome Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 2 ranking categories Overview

Avid Bioservices is a biologics CDMO focused on mammalian cell culture, process development, clinical manufacturing, commercial manufacturing, and related analytical services. The company serves biotechnology and pharmaceutical sponsors developing monoclonal antibodies, recombinant proteins, enzymes, and other biologic products.

Avance Clinical is an Australian CRO focused on supporting biotechnology companies through early-phase and later-stage clinical development programs. The company is especially relevant for sponsors seeking to use Australia’s clinical trial environment, regulatory pathways, and investigator networks.

Autolus Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier II Cell & Gene Therapy Developers 1 ranking category Overview

AstraZeneca Rare Disease, built around Alexion, remains one of the leading rare disease platforms globally. The business is especially associated with complement biology and severe rare disorders affecting hematology, nephrology, neurology, and metabolic disease.

Astellas Pharma is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Global Pharmaceutical Companies 1 ranking category Overview

Ascendis Pharma is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 1 ranking category Overview

Arrowhead Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 1 ranking category Overview

argenx has become one of the most important rare disease and specialty immunology developers globally. Its platform is focused on antibody-based medicines for severe autoimmune diseases, including rare neuromuscular and immune-mediated conditions requiring specialist care.

Ardena is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

Arcturus Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

Arcellx is a specialist cell therapy developer focused on engineered cellular therapies for cancer, particularly multiple myeloma. Its lead program, anitocabtagene autoleucel, has become one of the most closely watched next-generation BCMA-directed CAR-T candidates.

Apellis Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 2 ranking categories Overview

ANI Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Specialty Pharma Companies 1 ranking category Overview

Amneal Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Specialty Pharma Companies 1 ranking category Overview

Amicus Therapeutics is an established rare disease company focused on rare metabolic disorders, particularly Fabry disease and Pompe disease. The company has built its platform around precision therapy for genetically defined lysosomal storage and metabolic conditions.

Amgen remains one of the most important biotechnology firms globally and one of the defining companies in the history of the modern biotechnology industry. The company has evolved from a pioneer of recombinant biologics into a global biopharmaceutical organization with substantial commercial scale, manufacturing depth, and pipeline breadth.